RSS-Feed abonnieren
DOI: 10.1055/s-0031-1297166
Clinical and Laboratory Assessment of the Bleeding Pediatric Patient
Publikationsverlauf
Publikationsdatum:
20. Dezember 2011 (online)

ABSTRACT
Children presenting with bleeding symptoms pose a diagnostic challenge. The evaluation should include a comprehensive medical and bleeding history, detailed family history, a physical examination, and selected laboratory tests. Evaluation of the bleeding history should include an objective quantitation of the bleeding symptoms, followed by objective quantitation of the family members' bleeding symptoms. If a bleeding disorder is suspected, based on personal and/or family bleeding history, specific laboratory testing is needed for attaining a diagnosis. The screening tests for coagulation factor deficiencies are considered reliable, routinely available, and easy to perform. However, for primary hemostatic defects, the various screening tests have not yet proven to be reliable and thus referral for a specialized hematology consultation and specific laboratory testing are needed. Perhaps a Bayes theorem approach, combining the personal and family bleeding history with the results of a screening test for a primary hemostatic defect would prove to be useful in the identification of those children who will most benefit from specific laboratory testing.
KEYWORDS
Bleeding disorder - assessment - children - bleeding questionnaires - laboratory screening
REFERENCES
- 1
Werner E J, Broxson E H, Tucker E L, Giroux D S, Shults J, Abshire T C.
Prevalence of von Willebrand disease in children: a multiethnic study.
J Pediatr.
1993;
123
(6)
893-898
Reference Ris Wihthout Link
- 2
Bowman M, Hopman W M, Rapson D, Lillicrap D, James P.
The prevalence of symptomatic von Willebrand disease in primary care practice.
J Thromb Haemost.
2010;
8
(1)
213-216
Reference Ris Wihthout Link
- 3
Bowman M, Hopman W M, Rapson D, Lillicrap D, Silva M, James P.
A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD)
in a pediatric primary care population.
Pediatr Blood Cancer.
2010;
55
(1)
171-173
Reference Ris Wihthout Link
- 4
Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M.
Rare bleeding disorders.
Haemophilia.
2008;
14
(Suppl 3)
202-210
Reference Ris Wihthout Link
- 5
Salles I I, Feys H B, Iserbyt B F, De Meyer S F, Vanhoorelbeke K, Deckmyn H.
Inherited traits affecting platelet function.
Blood Rev.
2008;
22
(3)
155-172
Reference Ris Wihthout Link
- 6
Nurden P, Nurden A T.
Congenital disorders associated with platelet dysfunctions.
Thromb Haemost.
2008;
99
(2)
253-263
Reference Ris Wihthout Link
- 7
Hayward C P, Rao A K, Cattaneo M.
Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation
and treatment.
Haemophilia.
2006;
12
(Suppl 3)
128-136
Reference Ris Wihthout Link
- 8
Blanchette V S, Bolton-Maggs P.
Childhood immune thrombocytopenic purpura: diagnosis and management.
Pediatr Clin North Am.
2008;
55
(2)
393-420, ix
Reference Ris Wihthout Link
- 9
Cines D B, Bussel J B, McMillan R B, Zehnder J L.
Congenital and acquired thrombocytopenia.
Hematology (Am Soc Hematol Educ Program).
2004;
390-406
Reference Ris Wihthout Link
- 10
Anwar R, Minford A, Gallivan L, Trinh C H, Markham A F.
Delayed umbilical bleeding—a presenting feature for factor XIII deficiency: clinical
features, genetics, and management.
Pediatrics.
2002;
109
(2)
E32
Reference Ris Wihthout Link
- 11 Carcao M D, Blanchette V S. Work-up of a bleeding child. In: Lee C, Berntorp E, Hoots K, eds. Textbook of Hemophilia. 2nd ed. West, Sussex, UK: Blackwell; 2010: 118-126
Reference Ris Wihthout Link
- 12
Seligsohn U.
Factor XI deficiency in humans.
J Thromb Haemost.
2009;
7
(Suppl 1)
84-87
Reference Ris Wihthout Link
- 13
Simon D, Kunicki T, Nugent D.
Platelet function defects.
Haemophilia.
2008;
14
(6)
1240-1249
Reference Ris Wihthout Link
- 14
Nosek-Cenkowska B, Cheang M S, Pizzi N J, Israels E D, Gerrard J M.
Bleeding/bruising symptomatology in children with and without bleeding disorders.
Thromb Haemost.
1991;
65
(3)
237-241
Reference Ris Wihthout Link
- 15
Lillicrap D, Nair S C, Srivastava A, Rodeghiero F, Pabinger I, Federici A B.
Laboratory issues in bleeding disorders.
Haemophilia.
2006;
12
(Suppl 3)
68-75
Reference Ris Wihthout Link
- 16
Rodeghiero F, Kadir R A, Tosetto A, James P D.
Relevance of quantitative assessment of bleeding in haemorrhagic disorders.
Haemophilia.
2008;
14
(Suppl 3)
68-75
Reference Ris Wihthout Link
- 17
Rodeghiero F, Castaman G, Tosetto A et al..
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand
disease: an international, multicenter study.
J Thromb Haemost.
2005;
3
(12)
2619-2626
Reference Ris Wihthout Link
- 18
Tosetto A, Rodeghiero F, Castaman G et al..
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results
from a multicenter European study (MCMDM-1 VWD).
J Thromb Haemost.
2006;
4
(4)
766-773
Reference Ris Wihthout Link
- 19
Bowman M, Riddel J, Rand M L, Tosetto A, Silva M, James P D.
Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding
questionnaire.
J Thromb Haemost.
2009;
7
(8)
1418-1421
Reference Ris Wihthout Link
- 20
Biss T T, Blanchette V S, Clark D S et al..
Quantitation of bleeding symptoms in children with von Willebrand disease: use of
a standardized pediatric bleeding questionnaire.
J Thromb Haemost.
2010;
8
(5)
950-956
Reference Ris Wihthout Link
- 21
Biss T T, Blanchette V S, Clark D S, Wakefield C D, James P D, Rand M L.
Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding
symptoms in children with a platelet function disorder.
J Thromb Haemost.
2010;
8
(6)
1416-1419
Reference Ris Wihthout Link
- 22
Tosetto A, Castaman G, Rodeghiero F.
Bleeding scores in inherited bleeding disorders: clinical or research tools?.
Haemophilia.
2008;
14
(3)
415-422
Reference Ris Wihthout Link
- 23 Clinical and Laboratory Standards Institute .Platelet Function Testing By Aggregometry; Approved Guideline. 2008 Vol. 28, No. 31
Reference Ris Wihthout Link
- 24
Cariappa R, Wilhite T R, Parvin C A, Luchtman-Jones L.
Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected
hemorrhagic problems.
J Pediatr Hematol Oncol.
2003;
25
(6)
474-479
Reference Ris Wihthout Link
- 25
Schlammadinger A, Kerenyi A, Muszbek L, Boda Z.
Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory
diagnosis of von Willebrand's disease.
Thromb Haemost.
2000;
84
(1)
88-92
Reference Ris Wihthout Link
- 26
Posan E, McBane R D, Grill D E, Motsko C L, Nichols W L.
Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction
and von Willebrand disease in clinical practice.
Thromb Haemost.
2003;
90
(3)
483-490
Reference Ris Wihthout Link
- 27
Quiroga T, Goycoolea M, Muñoz B et al..
Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary
mucocutaneous hemorrhages: comparative study in 148 patients.
J Thromb Haemost.
2004;
2
(6)
892-898
Reference Ris Wihthout Link
- 28
Kundu S K, Heilmann E J, Sio R, Garcia C, Davidson R M, Ostgaard R A.
Description of an in vitro platelet function analyzer—PFA-100.
Semin Thromb Hemost.
1995;
21
(Suppl 2)
106-112
Reference Ris Wihthout Link
- 29
Favaloro E J, Facey D, Henniker A.
Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances
in von Willebrand factor to screen for von Willebrand's disease and other disorders.
Am J Hematol.
1999;
62
(3)
165-174
Reference Ris Wihthout Link
- 30
Francis J, Francis D, Larson L, Helms E, Garcia M.
Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding
time in routine clinical practice?.
Platelets.
1999;
10
(2-3)
132-136
Reference Ris Wihthout Link
- 31
Carcao M D, Blanchette V S, Dean J A et al..
The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of
primary haemostasis in children.
Br J Haematol.
1998;
101
(1)
70-73
Reference Ris Wihthout Link
- 32
Karger R, Donner-Banzhoff N, Müller H H, Kretschmer V, Hunink M.
Diagnostic performance of the platelet function analyzer (PFA-100) for the detection
of disorders of primary haemostasis in patients with a bleeding history-a systematic
review and meta-analysis.
Platelets.
2007;
18
(4)
249-260
Reference Ris Wihthout Link
- 33
Hayward C P, Harrison P, Cattaneo M, Ortel T L, Rao A K.
Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders
and platelet function.
J Thromb Haemost.
2006;
4
312-319
Reference Ris Wihthout Link
- 34
Kratzer M AA, Kretschmer V.
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function—a rebuttal.
J Thromb Haemost.
2006;
4
1429-1431
Reference Ris Wihthout Link
- 35
Koscielny J, Kiesewetter H, von Tempelhoff G F.
More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet
disorders and platelet function.
J Thromb Haemost.
2006;
4
(6)
1426-1427, discussion 1428–1434
Reference Ris Wihthout Link
- 36
Varon D, Dardik R, Shenkman B et al..
A new method for quantitative analysis of whole blood platelet interaction with extracellular
matrix under flow conditions.
Thromb Res.
1997;
85
(4)
283-294
Reference Ris Wihthout Link
- 37
Revel-Vilk S, Varon D, Shai E et al..
Evaluation of children with a suspected bleeding disorder applying the Impact-R [Cone
And Plate(Let) Analyzer].
J Thromb Haemost.
2009;
7
1990-1996
Reference Ris Wihthout Link
- 38
Quiroga T, Goycoolea M, Giesen P L et al..
Thrombin generation in platelet-poor plasma is normal in patients with hereditary
mucocutaneous haemorrhages.
Pathophysiol Haemost Thromb.
2003;
33
(1)
30-35
Reference Ris Wihthout Link
- 39
Eugster M, Reinhart W H.
The influence of the haematocrit on primary haemostasis in vitro.
Thromb Haemost.
2005;
94
(6)
1213-1218
Reference Ris Wihthout Link
- 40
Carcao M D, Blanchette V S, Stephens D et al..
Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100).
Br J Haematol.
2002;
117
(4)
961-964
Reference Ris Wihthout Link
- 41
Tosetto A, Castaman G, Rodeghiero F.
Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.
Blood.
2008;
111
(8)
3998-4003
Reference Ris Wihthout Link
- 42
Acharya S S, Coughlin A, Dimichele D M. North American Rare Bleeding Disorder Study Group .
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen
and dysfibrinogenemias.
J Thromb Haemost.
2004;
2
(2)
248-256
Reference Ris Wihthout Link
- 43
Bernardi F, Dolce A, Pinotti M International Factor VII Deficiency Study Group et al.
Major differences in bleeding symptoms between factor VII deficiency and hemophilia
B.
J Thromb Haemost.
2009;
7
(5)
774-779
Reference Ris Wihthout Link
- 44
Plug I, Mauser-Bunschoten E P, Bröcker-Vriends A H et al..
Bleeding in carriers of hemophilia.
Blood.
2006;
108
(1)
52-56
Reference Ris Wihthout Link
- 45
Hsieh L, Nugent D.
Factor XIII deficiency.
Haemophilia.
2008;
14
(6)
1190-1200
Reference Ris Wihthout Link
- 46
Spreafico M, Peyvandi F.
Combined factor V and factor VIII deficiency.
Semin Thromb Hemost.
2009;
35
(4)
390-399
Reference Ris Wihthout Link
- 47
Nichols W L, Hultin M B, James A H et al..
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines,
the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
Haemophilia.
2008;
14
(2)
171-232
Reference Ris Wihthout Link
- 48
Nurden A T, Nurden P.
The gray platelet syndrome: clinical spectrum of the disease.
Blood Rev.
2007;
21
(1)
21-36
Reference Ris Wihthout Link
- 49
Althaus K, Greinacher A.
MYH9-related platelet disorders.
Semin Thromb Hemost.
2009;
35
(2)
189-203
Reference Ris Wihthout Link
- 50
Rao A K.
Inherited defects in platelet signaling mechanisms.
J Thromb Haemost.
2003;
1
(4)
671-681
Reference Ris Wihthout Link
- 51
Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M.
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.
Blood.
2009;
113
(25)
6288-6295
Reference Ris Wihthout Link
- 52
Albert M H, Bittner T C, Nonoyama S et al..
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term
outcome, and treatment options.
Blood.
2010;
115
(16)
3231-3238
Reference Ris Wihthout Link
- 53
Owen C.
Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).
Leuk Res.
2010;
34
(2)
141-142
Reference Ris Wihthout Link
- 54
Ballmaier M, Germeshausen M.
Advances in the understanding of congenital amegakaryocytic thrombocytopenia.
Br J Haematol.
2009;
146
(1)
3-16
Reference Ris Wihthout Link
- 55
Geddis A E, Kaushansky K.
Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet
production.
Curr Opin Pediatr.
2004;
16
(1)
15-22
Reference Ris Wihthout Link
- 56 Toriello H V. Thrombocytopenia absent radius syndrome. In: Genereviews [Internet]. Seattle, WA: University of Washington; 2009
Reference Ris Wihthout Link
- 57
Pham A, Wang J.
Bernard-Soulier syndrome: an inherited platelet disorder.
Arch Pathol Lab Med.
2007;
131
(12)
1834-1836
Reference Ris Wihthout Link
- 58
Pallotta R, Evangelista V, Margaglione M, Bucci I, Saponari A.
Macrothrombocytopenia in velocardiofacial syndrome.
J Thromb Haemost.
2005;
3
(3)
601-603
Reference Ris Wihthout Link
- 59
Favaloro E J.
Phenotypic identification of platelet-type von Willebrand disease and its discrimination
from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical
twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?.
Semin Thromb Hemost.
2008;
34
(1)
113-127
Reference Ris Wihthout Link
- 60
Behrens W E.
Mediterranean macrothrombocytopenia.
Blood.
1975;
46
(2)
199-208
Reference Ris Wihthout Link
- 61 Kacena M A, Kirk J, Chou S T, Weiss M J, Raskind W H. GATA1-related X-linked cytopenia. In: Pagon R A, Bird T D, Dolan C R, Stephens K, eds. GeneReviews [Internet]. University of Washington, Seattle, 2006
Reference Ris Wihthout Link
- 62
Gunay-Aygun M, Zivony-Elboum Y, Gumruk F et al..
Gray platelet syndrome: natural history of a large patient cohort and locus assignment
to chromosome 3p.
Blood.
2010;
116
(23)
4990-5001
Reference Ris Wihthout Link
Shoshana Revel-VilkM.D. M.Sc.
Department of Pediatric Hematology/Oncology, Hadassah Hebrew University Hospital
POB 12000, Jerusalem 91200, Israel
eMail: shoshanav@hadassah.org.il